Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Personal Finance Center Mortgages Loans Investing & Retirement Spending & Savings

Calculators

401k Retirement Calculator Mortgage Calculator

Compound Interest Calculator Dollar Cost Averaging

Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks TipRanks Community Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

Follow Us

News Smart Portfolio Expert Center TipRanksAI

TOOLS

Earnings Calendar

Daily Analyst Ratings

STOCKS

ADVANCED RESEARCH

TipRanks Premium

Invest Like a Pro with Unique Data & Simplifed ToolsTry Now

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

TipRanks Community

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

MLYS Stock Latest News

Goldman Sachs Predicts Over 120% Rally for These 2 ‘Strong Buy’ Stocks

Stock Analysis & IdeasGoldman Sachs Predicts Over 120% Rally for These 2 ‘Strong Buy’ Stocks

Mineralys Therapeutics Board Member Announces Departure

PremiumCompany Announcements

Mineralys Therapeutics Board Member Announces Departure

20d ago

Mineralys Therapeutics initiated with a Buy at Goldman Sachs

PremiumThe Fly

Mineralys Therapeutics initiated with a Buy at Goldman Sachs

22d ago

Mineralys Therapeutics initiated with an Outperform at LifeSci Capital

PremiumThe Fly

Mineralys Therapeutics initiated with an Outperform at LifeSci Capital

29d ago

Mineralys Therapeutics files to sell 8.89M shares of common stock for holders

PremiumThe Fly

Mineralys Therapeutics files to sell 8.89M shares of common stock for holders

1M ago

Mineralys Therapeutics files $500M mixed securities shelf

PremiumThe FlyMineralys Therapeutics files $500M mixed securities shelf

1M ago

Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

PremiumPress Releases

Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

1M ago

Mineralys Therapeutics reports Q4 EPS (61c), consensus (82c)

PremiumThe Fly

Mineralys Therapeutics reports Q4 EPS (61c), consensus (82c)

1M ago

Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024

PremiumPress Releases

Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024

1M ago

MLYS Earnings this Week: How Will it Perform?

PremiumPre-Earnings

MLYS Earnings this Week: How Will it Perform?

1M ago

Mineralys Therapeutics Announces Strategic Purchase Agreement

PremiumCompany Announcements

Mineralys Therapeutics Announces Strategic Purchase Agreement

2M ago

Mineralys Therapeutics Equity Sales: Investor Impact Report

PremiumCompany Announcements

Mineralys Therapeutics Equity Sales: Investor Impact Report

2M ago

Mineralys Therapeutics Secures $120M in Private Placement

PremiumCompany AnnouncementsMineralys Therapeutics Secures $120M in Private Placement

2M ago

Mineralys Therapeutics to sell 8.9M shares at $13.50 in private placement

PremiumThe Fly

Mineralys Therapeutics to sell 8.9M shares at $13.50 in private placement

3M ago

Mineralys Therapeutics Announces $120 Million Private Placement Financing

PremiumPress Releases

Mineralys Therapeutics Announces $120 Million Private Placement Financing

3M ago

Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference

PremiumPress Releases

Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference

3M ago

Mineralys Therapeutics names Minji Kim, Ph.D. as Chief Business Officer

PremiumThe Fly

Mineralys Therapeutics names Minji Kim, Ph.D. as Chief Business Officer

4M ago

Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer

PremiumPress Releases

Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer

4M ago

Mineralys Therapeutics doses first subject in Launch-HTN pivotal trial

PremiumThe Fly

Mineralys Therapeutics doses first subject in Launch-HTN pivotal trial

4M ago

Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension

PremiumPress ReleasesMineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension

4M ago

Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023

PremiumPress Releases

Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023

5M ago

Mineralys Therapeutics reports Q3 EPS (57c), consensus (76c)

PremiumThe Fly

Mineralys Therapeutics reports Q3 EPS (57c), consensus (76c)

6M ago

Trending

S&P 500

Dow Jones

Nasdaq 100

More Trending Stocks >